021-51111890
购物车（）
sales@molnova.cn
Fosravuconazole L-lysine ethanolate
CAS No. 914361-45-8
Fosravuconazole L-lysine ethanolate ( BMS-379224 L-lysine ethanolate; E-1224 L-lysine ethanolate )
产品货号. M24954 CAS No. 914361-45-8
FosravuconazoleL-lysine ethanolate is a broad-spectrum antifungal agent. In Japan, it is approved for the treatment of onychomycosis, a fungal infection of the nail. It is a prodrug that is converted into ravuconazole.
纯度: >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| 规格 | 价格/人民币 | 库存 | 数量 |
| 2MG | ￥429 | 有现货 |
|
| 5MG | ￥616 | 有现货 |
|
| 10MG | ￥988 | 有现货 |
|
| 25MG | ￥1936 | 有现货 |
|
| 50MG | ￥3062 | 有现货 |
|
| 100MG | ￥5038 | 有现货 |
|
| 200MG | ￥7120 | 有现货 |
|
| 500MG | 获取报价 | 有现货 |
|
| 1G | 获取报价 | 有现货 |
|
生物学信息
-
产品名称Fosravuconazole L-lysine ethanolate
-
注意事项本公司产品仅用于科研实验，不得用于人体或动物的临床与诊断
-
产品简述FosravuconazoleL-lysine ethanolate is a broad-spectrum antifungal agent. In Japan, it is approved for the treatment of onychomycosis, a fungal infection of the nail. It is a prodrug that is converted into ravuconazole.
-
产品描述FosravuconazoleL-lysine ethanolate is a broad-spectrum antifungal agent. In Japan, it is approved for the treatment of onychomycosis, a fungal infection of the nail. It is a prodrug that is converted into ravuconazole.
-
同义词BMS-379224 L-lysine ethanolate; E-1224 L-lysine ethanolate
-
通路Others
-
靶点Other Targets
-
受体Others
-
研究领域——
-
适应症——
化学信息
-
CAS Number914361-45-8
-
分子量739.7
-
分子式C31H40F2N7O8PS
-
纯度>98% (HPLC)
-
溶解度DMSO:48mg/mL (64.89mM)
-
SMILESN#CC1=CC=C(C2=CSC([C@H](C)[C@@](OCOP(O)(O)=O)(C3=CC=C(F)C=C3F)CN4N=CN=C4)=N2)C=C1.CCO.N[C@H](C(O)=O)CCCCN
-
化学全称——
运输与储存
-
储存条件(-20℃)
-
运输条件With Ice Pack
-
稳定性≥ 2 years
参考文献
1.Diniz LF, Mazzeti AL, Caldas IS, Ribeiro I, Bahia MT. Outcome of E1224-Benznidazole Combination Treatment for Infection with a Multidrug-Resistant Trypanosoma cruzi Strain in Mice. Antimicrob Agents Chemother. 2018;62(6):e00401-18. Published 2018 May 25. doi:10.1128/AAC.00401-18Watanabe S, Tsubouchi I, Okubo A. Efficacy and safety of fosravuconazole L-lysine ethanolate, a novel oral triazole antifungal agent, for the treatment of onychomycosis: A multicenter, double-blind, randomized phase III study. J Dermatol. 2018;45(10):1151-1159. doi:10.1111/1346-8138.14607
产品手册
关联产品
-
NBD-F
NBD-F is a fluorescent derivatization compound for amino acid analysis.
-
Methyl nomilinate
Methyl nomilinate from citrus can modulate cell cycle regulators to induce cytotoxicity in human colon cancer (SW480) cells in vitro.
-
AKOS025692697
AKOS025692697 is a biochemical.
